Abstract
Erythroplasia of Queyrat (EQ) is a carcinoma in situ of the mucosal surface of the penis. Poor hygiene and local irritation, as well as coinfection with HPV-8 and HPV-16, are potential risk factors. It presents as a well-demarcated, velvety red plaque of variable size, with smooth surface, involving the glans penis or the inner surface of the prepucial skin and may progress to invasive squamous cell carcinoma in 10–33% of the cases. Treatment of choice is surgical excision of the lesion, but preservation of functionality of the penis and of the sexual activity may pose limitations to the extent and radicality of surgery. Safety margins of at least 5 mm are generally acceptable for excision, which on most occasions result in large defects. Therefore, Mohs micrographic surgery is suggested in an effort to spare unaffected tissue. Carbon dioxide or neodymium:YAG laser therapy and the application of 5-fluorouracil cream or imiquimod cream are the main alternatives to surgery in order to preserve function without affecting sexual activity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahmed I, Berth-Jones J, Charles-Holmes S, O’Callaghan CJ, Ilchyshyn A. Comparison of cryotherapy with curettage in the treatment of Bowen’s disease: a prospective study. Br J Dermatol. 2000;143(4):759–66.
Alnajjar HM, Lam W, Bolgeri M, Rees RW, Perry MJ, Watkin NA. Treatment of carcinoma in situ of the glans penis with topical chemotherapy agents. Eur Urol. 2012;62(5):923–8.
Angerer-Shpilenya M, Gaisa NT, Jakse G. Excision of carcinoma in situ of the glans penis with reconstructive plastic surgery. Urologe A. 2010;49(3):392–5.
Bunker CB, Neill SM. The genital, perianal and umbilical regions. In: Burns T, Breathnach SM, Cox N, Griffiths C, editors. Rook’s textbook of dermatology, vol. vol. 4. 8th ed. Oxford: Blackwell Science; 2010. p. 71.38–9.
Calzavara-Pinton PG, Rossi MT, Sala R, Italian Group For Photodynamic Therapy. A retrospective analysis of real-life practice of off-label photodynamic therapy using methyl aminolevulinate (MAL-PDT) in 20 Italian dermatology departments. Part 2: oncologic and infectious indications. Photochem Photobiol Sci. 2013;12(1):158–65.
Chan S-L, Watchorn RE, Panagou E, Panou E, Ong ELH, Kara Heelan K, Haider A, Freeman A, Bunker CB. Dermatoscopic findings of penile intraepithelial neoplasia: bowenoid papulosis, bowen disease and erythroplasia of Queyrat. Australas J Dermatol. 2019;60(3):e201–7.
Conejo-Mir JS, Muñoz MA, Linares M, Rodríguez L, Serrano A. Carbon dioxide laser treatment of erythroplasia of Queyrat: a revisited treatment to this condition. J Eur Acad Dermatol Venereol. 2005;19(5):643–4.
Crispen PL, Mydlo JH. Penile intraepithelial neoplasia and other premalignant lesions of the penis. Urol Clin North Am. 2010;37(3):335–42.
Deen K, Burdon-Jones D. Imiquimod in the treatment of penile intraepithelial neoplasia: an update. Australas J Dermatol. 2017;58(2):86–92.
Errichetti E, Lallas A, Di Stefani A, Apalla Z, Kyrgidis A, Lacarrubba F, Micali G, Galvan A, Piaserico S, Stinco G. Accuracy of dermoscopy in distinguishing erythroplasia of Queyrat from common forms of chronic balanitis: results from a multicentric observational study. J Eur Acad Dermatol Venereol. 2019;33(5):966–72.
Fai D, Romano I, Cassano N, Vena GA. Methyl-aminolevulinate photodynamic therapy for the treatment of erythroplasia of Queyrat in 23 patients. J Dermatolog Treat. 2012;23(5):330–2.
Fanning DM, Flood H. Erythroplasia of Queyrat. Clin Pract. 2012;2(3):e63.
Feldmeyer L, Krausz-Enderlin V, Töndury B, Hafner J, French LE, Hofbauer GFL. Methylaminolaevulinic acid photodynamic therapy in the treatment of erythroplasia of Queyrat. Dermatology. 2011;223(1):52–6.
Goette DK, Carson TE. Erythroplasia of Queyrat: treatment with topical 5-fluorouracil. Cancer. 1976;38(4):1498–502.
Graham JH, Helwig EB. Erythroplasia of Queyrat. A clinicopathologic and histochemical study. Cancer. 1973;32(6):1396–414.
Hadway P, Corbishley CM, Watkin NA. Total glans resurfacing for premalignant lesions of the penis: initial outcome data. BJU Int. 2006;98(3):532–6.
Kim B, Garcia F, Touma N, Moussa M, Izawa JI. A rare case of penile cancer in situ metastasizing to lymph nodes. Can Urol Assoc J. 2007;1(4):404–7.
Kutlubay Z, Engin B, Zara T, Tüzün Y. Anogenital malignancies and premalignancies: facts and controversies. Clin Dermatol. 2013;31(4):362–73.
Lee MR, Ryman W. Erythroplasia of Queyrat treated with topical methyl aminolevulinate photodynamic therapy. Australas J Dermatol. 2005;46(3):196–8.
Malloy TR, Wein AJ, Carpiniello VL. Carcinoma of penis treated with neodymium YAG laser. Urology. 1988;31(1):26–9.
Maranda EL, Nguyen AH, Lim VM, Shah VV, Jimenez JJ. Erythroplasia of Queyrat treated by laser and light modalities: a systematic review. Lasers Med Sci. 2016;31(9):1971–6.
McLean M, Akl AM, Warde P, Bissett R, Panzarella T, Gospodarowicz M. The results of primary radiation therapy in the management of squamous cell carcinoma of the penis. Int J Radiat Oncol Biol Phys. 1993;25(4):623–8.
Meijer RP, Boon TA, van Venrooij GE, Wijburg CJ. Long-term follow-up after laser therapy for penile carcinoma. Urology. 2007;69(4):759–62.
Sonnex TS, Ralfs IG, Plaza de Lanza M, Dawber RP. Treatment of erythroplasia of Queyrat with liquid nitrogen cryosurgery. Br J Dermatol. 1982;106(5):581–4.
Stables GI, Stringer MR, Robinson DJ, Ash DV. Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy. Br J Dermatol. 1999;140(3):514–7.
Tietjen DN, Malek RS. Laser therapy of squamous cell dysplasia and carcinoma of the penis. Urology. 1998;52(4):559–65.
van Bezooijen BP, Horenblas S, Meinhardt W, Newling DW. Laser therapy for carcinoma in situ of the penis. J Urol. 2001;166(5):1670–1.
Varma S, Holt PJ, Anstey AV. Erythroplasia of queyrat treated by topical aminolaevulinic acid photodynamic therapy: a cautionary tale. Br J Dermatol. 2000;142(4):825–6.
Wieland U, Jurk S, Weissenborn S, Krieg T, Pfister H, Ritzkowsky A. Erythroplasia of queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ. J Invest Dermatol. 2000;115(3):396–401.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Krasagakis, K. (2023). Erythroplasia of Queyrat. In: Katsambas, A.D., Lotti, T.M., Dessinioti, C., D'Erme, A.M. (eds) European Handbook of Dermatological Treatments. Springer, Cham. https://doi.org/10.1007/978-3-031-15130-9_30
Download citation
DOI: https://doi.org/10.1007/978-3-031-15130-9_30
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-15129-3
Online ISBN: 978-3-031-15130-9
eBook Packages: MedicineMedicine (R0)